Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | MME | P08473 | 6/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 12/20 | 0.35 |
| ▸ | PTPRF | P10586 | 1/20 | 0.35 |
| ▸ | PTPRA | P18433 | 1/20 | 0.35 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5768014 | 0.92 | PTPN1 (0.40) | MMEPTPN1PTPRFPTPRAPTPN7 | |
| SCHEMBL4267609 | 0.80 | PTPN1 (0.47) | MMP2MMP13PTPN1PTPRFPTPRA | |
| SCHEMBL4274370 | 0.78 | ADAMTS4 (0.35) | ADAMTS4MMP2MMP13MMP14MME | |
| SCHEMBL4800199 | 0.77 | PTPN1 (0.38) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4264218 | 0.77 | MTNR1A (0.40) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4806726 | 0.75 | PTPN1 (0.38) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL4274537 | 0.72 | PTPN1 (0.55) | PTPN1PTPRFPTPRAPTPN7DUSP3 | |
| SCHEMBL5187438 | 0.72 | PTPN1 (0.39) | ADAMTS4MMP2MMP13MMP14PTPN1 | |
| SCHEMBL4275242 | 0.71 | MMP2 (0.40) | ADAMTS4MMP2MMP13MMP14PTPN1 | |
| SCHEMBL4264656 | 0.71 | PPARA (0.35) | MMEPTPN1DUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090082392-A1 | Substituted Carboxylic Acids | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC | 2009-03-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082392-A1 | Substituted Carboxylic Acids | PTPRJ, PTPRS, PTPRG | ADAMTS4 4500/4885MMP2 3614/4885MMP13 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.